These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11256365)

  • 41. Molecular testing for hereditary hemochromatosis.
    Liang Q; Lichy JH
    Expert Rev Mol Diagn; 2002 Jan; 2(1):49-59. PubMed ID: 11963802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Noll WW; Belloni DR; Stenzel TT; Grody WW
    Nat Genet; 1999 Nov; 23(3):271-2. PubMed ID: 10610176
    [No Abstract]   [Full Text] [Related]  

  • 43. Introduction: Hemochromatosis population screening.
    Beutler E
    Genet Test; 2000; 4(2):95-6. PubMed ID: 10953945
    [No Abstract]   [Full Text] [Related]  

  • 44. Best practice guidelines for the molecular genetic diagnosis of Type 1 (HFE-related) hereditary haemochromatosis.
    King C; Barton DE
    BMC Med Genet; 2006 Nov; 7():81. PubMed ID: 17134494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hereditary haemochromatosis.
    Janssen MC; Swinkels DW
    Best Pract Res Clin Gastroenterol; 2009; 23(2):171-83. PubMed ID: 19414144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of hereditary hemochromatosis and biochemical iron overload in primary care: a multicenter case finding study in Spain.
    Freixenet N; Moreno-Rosel MS; Barceló MJ; Serrano A; Payà M; Crespo L; Pérez-Lucena MJ; Altés A; Baiget M; Félez J
    Am J Hematol; 2010 Apr; 85(4):294-6. PubMed ID: 20196172
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening for genetic haemochromatosis in a rheumatology clinic.
    Buchbinder R; Hall S
    Aust N Z J Med; 1994 Oct; 24(5):588-9. PubMed ID: 7848175
    [No Abstract]   [Full Text] [Related]  

  • 48. [Screening for hereditary hemochromatosis?].
    Møller P
    Tidsskr Nor Laegeforen; 2005 Apr; 125(8):1044-5; author reply 1045. PubMed ID: 15852086
    [No Abstract]   [Full Text] [Related]  

  • 49. [Screening for hereditary hemochromatosis].
    Birgens HS; Hansen NE
    Ugeskr Laeger; 2002 Jun; 164(23):3083-4; discussion 3084-5. PubMed ID: 12082869
    [No Abstract]   [Full Text] [Related]  

  • 50. A Systematic Review and Narrative Synthesis of Health Economic Studies Conducted for Hereditary Haemochromatosis.
    de Graaff B; Neil A; Sanderson K; Si L; Yee KC; Palmer AJ
    Appl Health Econ Health Policy; 2015 Oct; 13(5):469-83. PubMed ID: 26255179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results.
    Gomez PS; Parks S; Ries R; Tran TC; Gomez PF; Press RD
    Nat Genet; 1999 Nov; 23(3):272. PubMed ID: 10545944
    [No Abstract]   [Full Text] [Related]  

  • 52. Population screening for hemochromatosis: the evolving role of genetic analysis.
    Davis JG
    Ann Intern Med; 1998 Dec; 129(11):905-8. PubMed ID: 9867735
    [No Abstract]   [Full Text] [Related]  

  • 53. [Screening for hereditary hemochromatosis?].
    Asberg A
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):15. PubMed ID: 15643454
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetic testing.
    Pollack A; Miller G
    Aust Fam Physician; 2014 Jul; 43(7):427. PubMed ID: 25006599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of the introduction of a guideline on the targeted detection of hereditary haemochromatosis.
    Jacobs EM; Meulendijks CF; Elving L; van der Wilt GJ; Swinkels DW
    Neth J Med; 2005 Jun; 63(6):205-14. PubMed ID: 16011012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic discrimination and screening for hemochromatosis.
    Alper JS; Geller LN; Barash CI; Billings PR; Laden V; Natowicz MR
    J Public Health Policy; 1994; 15(3):345-58. PubMed ID: 7983195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and therapy of genetic haemochromatosis (review and 2017 update).
    Fitzsimons EJ; Cullis JO; Thomas DW; Tsochatzis E; Griffiths WJH;
    Br J Haematol; 2018 May; 181(3):293-303. PubMed ID: 29663319
    [No Abstract]   [Full Text] [Related]  

  • 59. Factors affecting the uptake of screening: a randomised controlled non-inferiority trial comparing a genotypic and a phenotypic strategy for screening for haemochromatosis.
    Patch C; Roderick P; Rosenberg W
    J Hepatol; 2005 Jul; 43(1):149-55. PubMed ID: 15876471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The prioritization of genetic screening with primary haemochromatosis as an example].
    Jacobs EM; Verbeek AL; Swinkels DW
    Ned Tijdschr Geneeskd; 2003 Nov; 147(46):2304-5; author reply 2305. PubMed ID: 14655303
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.